Savara SVRA
NASDAQ SVRA
$4.61 -0.07 (-1.39%)
As of: Oct 22, 2026 · 11:46 AM EDT

Savara (SVRA) FCF Margin (2015 - 2026)

Updated

Savara's FCF Margin came in at -1230500.00% for Q4 2020, down 1227873.83 percentage points from the prior quarter.

Analysis

Savara (SVRA) FCF Margin (2015 - 2026) Analysis & Trends

For FY2020, Savara's FCF Margin was -15518.68%.

  • FCF Margin carries a five-year change of -6364.97 percentage points (FY2015 to FY2020).
  • Going back by year, FCF Margin was -2094.50% in FY2016 (+7059.20 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,172.00 Bn 1,140.58 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 639.12 Bn 557.64 Bn 17.26 Bn 28.82%
3 AbbVie 502.23 Bn 475.34 Bn 12.70 Bn 18.33%
4 Merck 375.29 Bn 329.67 Bn 12.21 Bn 26.96%
5 Novartis Ag 302.99 Bn 266.98 Bn 11.24 Bn 38.60%
6 Astrazeneca 268.68 Bn 242.36 Bn 12.86 Bn 6.55%
7 Amgen 242.24 Bn 197.64 Bn 7.24 Bn 34.70%
8 Gilead Sciences 193.36 Bn 167.56 Bn 6.22 Bn 44.00%
9 Pfizer 172.57 Bn 119.21 Bn 10.94 Bn 2.01%
10 Savara 1.17 Bn 430.48 Mn - -3,615.92%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3,615.92%
Mar 31, 2026 -3,131.50%
Dec 31, 2025 -2,095.31%
Sep 30, 2025 -4,115.33%
Jun 30, 2025 -2,852.99%
Mar 31, 2025 -1,815.22%
Dec 31, 2024 -1,216.52%
Sep 30, 2024 -1,064.87%
Dec 31, 2023 -1,028.77%
Dec 31, 2022 -1,408.96%
Dec 31, 2020 -1,230,500.00%
Sep 30, 2020 -2,626.17%
Sep 30, 2019 -228,380.00%
Jun 30, 2019 -41,745.16%
Dec 31, 2018 -9,019.66%
Sep 30, 2018 -7,908.11%
Mar 31, 2017 -3,088.30%
Dec 31, 2016 -547.50%
Sep 30, 2016 -6,373.33%
Dec 31, 2015 35,764.81%
API Access

Savara FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=SVRA&period=max&api_key=YOUR_API_KEY